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Abstract: Metabolic syndrome includes a cluster of risk factors for many pathological conditions,
including hyperglycemia, abdominal obesity, hyperlipidemia, and hypertension. Adansonia digitata L.
(also known as baobab) is used in traditional African Medicine and recent studies showed that it
improves the metabolism of carbohydrates and lipids. The aim of this study is to investigate the
mechanisms of action associated with the beneficial effects of extracts from the edible parts of baobab
(fruit pulp, leaves, raw and toasted seeds), evaluating their inhibitory activity against: alpha-amylase,
alpha-glucosidase, angiotensin-converting enzyme, 3-hydroxy-3-methyl-glutaryl-coenzyme A
reductase, and pancreatic lipase. Baobab fruit pulp and leaf extracts resulted to be the most
active ones and were then tested on the differentiation process of SW-872 human liposarcoma cells
to mature adipocytes. The addition of these latter extracts did not affect triglyceride accumulation,
indicating a neutral impact on this parameter. The findings here reported help to explain the growing
amount of evidence on the biological properties of baobab and provide suggestions about their use in
food and nutraceutical fields.
Keywords: Adansonia digitata L.; baobab edible parts; digestive enzyme inhibition; ACE inhibition;
HMG-CoA reductase inhibition; SW-872 preadipocytes
1. Introduction
Metabolic syndrome (MS) is a condition of low-grade chronic inflammation generated by a
complex interplay between genetic and environmental factors. Generally, it provokes a cluster of risk
factors that include hyperglycemia, abdominal obesity, hyperlipidemia, and hypertension. It may
evolve in severe systemic effects such as stroke, coronary heart disease, myocardial infarction, type 2
Molecules 2020, 25, 2858; doi:10.3390/molecules25122858 www.mdpi.com/journal/molecules
Molecules 2020, 25, 2858 2 of 14
diabetes mellitus, cancer, and other diseases, which may lead to death [1]. The prevalence of MS in
the different regions of the world ranges from under 10% to as much as 84% [2–4]. Aetiology of MS
is mainly linked with unhealthy lifestyle; thus, its incidence is relatively common. MS prevention
might be achieved by adopting lifestyle changes (weight loss and increased physical activity) and
following a healthy diet characterized by high consumption of fruits, vegetables, and whole grains
and a low intake of trans fatty acids, cholesterol, and salt. Considering that maintaining a healthy
lifestyle is an everyday challenge and in some cases a simple change in lifestyle may be not effective,
specific pharmacological treatments are often prescribed (i.e., statins to decrease hypercholesterolemia,
renin-angiotensin-aldosterone system inhibitors for hypertension, metformin or sodium/glucose
cotransporter 2 inhibitors or glucagon-like peptide 1 receptor agonists (GLP-1RAs) for hyperglycemia,
and the GLP-1RA liraglutide to reduce obesity) [5]. Nevertheless, these drugs can exert serious side
effects that can lead to low therapy compliance, enhancing the risk to develop severe forms of the
above-mentioned pathologies. Moreover, a large portion of possible patients is not fully eligible for drug
treatment and may benefit from different approaches. In this context, the interest in functional foods
and food supplements able to reduce modifiable MS risk factors, such as anti-hypercholesterolemic
and anti-hyperglycemic agents, continues to increase [6].
Adansonia digitata L., known as baobab, is a plant indigenous to Africa. Its edible parts have a
significant and consolidated history of human consumption in this geographical area, where baobab is
used both as a food and in traditional African medicine against some disorders, including malaria,
tuberculosis, fever, microbial infections [7], gastrointestinal disorders (constipation and diarrhea),
anaemia, and toothache among others [8]. Almost all parts of this tree (fruit pulp, seeds, leaves, flowers,
roots, and bark) are used in the traditional African medicine [9,10], whereas, in Europe, only the
fruit pulp is consumed as a food since its authorization as a novel food ingredient by the European
parliament and council under the Regulation (EC) No. 258/97 (Commission Decision 2008/575/EC).
Furthermore, growing literature evidence suggests that Adansonia digitata L. can improve carbohydrates
and lipids metabolism, exerting hypoglycemic and hypolipidemic activities [11–14].
In this context, this study aimed to investigate the possible mechanisms of action underlying
the beneficial effects of baobab extracts observed in animal model systems. All the different edible
parts of the baobab (fruit pulp, leaves, raw seeds, and toasted seeds) are evaluated as possible sources
of advantage in reducing the main risk factors of MS. In detail, we tested the effect on the enzymes,
which play a crucial role in MS and above-mentioned related pathologies development: alpha-amylase,
alpha-glucosidase, angiotensin-converting enzyme (ACE), 3-hydroxy-3-methyl-glutaryl-coenzyme A
reductase (HMG-CoAR), and pancreatic lipase.
Thus, the extracts obtained from the edible parts of baobab were assayed by in vitro enzymatic
assays to evaluate their inhibitory capacity against these enzymes. As baobab fruit and leaf extracts
were found to be the most active, we continued in testing their potential activity on the differentiation
process of SW-872 human liposarcoma cells to mature adipocytes. Since these cells can be differentiated
to mature adipocytes upon treatment with 100 µM oleic acid for 7 days, they can actually be used as a
model for human adipocytes for studying the metabolism of lipids [15–17].
2. Results
2.1. Baobab Edible Part Extracts
As reported in the Materials and Methods section, baobab fruit pulp, leaves and raw and
toasted seeds were submitted for extraction. The extracts were freeze-dried and the yield of the
extraction procedure was evaluated. Baobab fruit pulp extract gave the highest yield (22.3%),
followed by baobab leaves (12.2%), while baobab raw and toasted seeds gave the lowest yield,
which was found to be 5.9% and 4.9%, respectively. The chemical characterization was performed
in a previous study of Tsetegho et al. (2019) although reverse-phase high-performance liquid
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chromatography with photodiode array detection coupled to electrospray ion-trap mass spectrometry
(RP-HPLC-PDA-ESI-MS/MS analysis) [18].
2.2. In Vitro Enzymatic Inhibition Assays
2.2.1. Alpha-Amylase Inhibition Assay
Figure 1A showed the results obtained from the alpha-amylase inhibition assay.
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extract; 5. Acarbose. IC50 values are also re . * means statistically significant difference (p < 0.05)
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Acarbose, a known inhibitor of alpha-amylase, inhibited the enzyme in a concentration-dependent
manner, with an IC50 of 0.036 mg/mL (Figure 1A5). As far as baobab leaf and fruit pulp extracts are
concerned (Figure 1A1,A2), they inhibited alpha-amylase activity in a concentration-dependent manner
with IC50 of 0.10 and 9.97 mg/mL, respectively. Baobab leaves showed the most potent activity against
alpha-amylase, although this activity was nearly three times lower than that of acarbose. Both raw and
toasted baobab seed extracts weakly inhibit alpha-amylase, though the raw seed extract seems to be
more active than toasted seeds (Figure 1A3,A4).
2.2.2. Alpha-Glucosidase Inhibition Assay
The results of alfa-glucosidase inhibition assay suggest that acarbose inhibited the enzyme activity
in a concentration-dependent manner with an IC50 of 0.66 mg/mL (Figure 1B5). The baobab leaf
and fruit pulp extracts also inhibited alpha-amylase in a concentration-dependent manner with
IC50 = 0.03 mg/mL and = 0.64 mg/mL, respectively (Figure 1B1,B2). Also, in this case, the baobab
leaf extract resulted in being more active than the fruit pulp extracts. In fact, the baobab leaf extract
showed the most potent activity against alpha-glucosidase with an IC50 lower than that obtained for
acarbose. Both raw and toasted baobab seeds weakly inhibited alpha-glucosidase, though in this case,
the toasted seeds appeared to be more active, unlike in the alpha-amylase assay results (Figure 1B3,B4).
2.2.3. ACE Inhibition Assay
In ACE inhibition assay, L-captopril was used as positive control. It inhibited the enzyme in a
concentration-dependent manner with an IC50 of 30 nM (Figure 2A5).
Under our experimental conditions, all baobab extracts inhibited ACE in a concentration-dependent
manner. In detail, the baobab leaf extract (Figure 2A2) showed the highest inhibition
(IC50 = 0.08 mg/mL) followed by the fruit pulp (IC50 = 1.7 mg/mL) (Figure 2A1), then the raw
seeds (IC50 = 7.77 mg/mL) (Figure 2A3) and the toasted seeds (IC50 = 17 mg/mL) (Figure 2A4).
2.2.4. HMG-CoAR Inhibition Assay
The data obtain to HMG-CoAR inhibition assay is reported in Figure 2B5, where pravastatin used
as the positive control inhibited HMG-CoAR in a concentration-dependent manner, with an IC50 of
22.70 µM. In our experimental conditions, the tested baobab extracts (Figure 2B1–4) were found to exert
very low inhibitory activity. In detail, baobab leaves showed the highest inhibitory activity against
HMG-CoAR with an IC50 of about 1.90 mg/mL, followed by the fruit pulp and raw seed extracts which
show an IC50 higher than 20 mg/mL. Baobab raw seed extract showed very low inhibition.
2.2.5. Pancreatic Lipase Inhibition Assay
Orlistat was used as positive control in the pancreatic lipase inhibition. This compound showed
dose-dependent inhibition with an IC50 = 1.94 ng/mL (Figure 2C3). As far as baobab extracts are
concerned, leaf extract (Figure 2C2) showed the most potent inhibitory activity with an IC50 of
1.85 mg/mL followed by baobab fruit pulp (Figure 2C1), which has an IC50 of 20.44 mg/mL. Baobab
raw and toasted seed extracts did not show any inhibition of pancreatic lipase (data not shown).
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and pancreatic lipase (C). The results are expressed as mean of percentage (%) inhibition (± SD).
Captopril, pravastatin, and orlistat were used as positive control at increasing concentrations. 1. Fruit
pulp extract; 2. Leaf extract; 3. Raw seed extract; 4. Toasted seed extract; 5. Pravastatin. IC50 values are
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2.3. Effects of Baobab Fruit Pulp and Leaf Extracts on the Differentiation of SW-872 Human Liposarcoma Cells
to Mature Adipocytes
As baobab fruit and leaf extracts were found to be the most active in terms of enzyme activity
inhibition, their effects on the process of adipocyte differentiation of SW-872 cells were tested.
2.3.1. Differentiation of SW-872 Preadipocytes to Adipocytes
SW-872 preadipocytes were differentiated to adipocytes with 100 µM oleic acid. Figure 3 shows
the ORO staining of SW-872 cells under non-differentiated (control) and differentiated (oleic acid)
conditions (Figure 3B). The marked red staining in differentiated SW-872 cells indicates the abundant
accumulation of TG (triglycerides), as expected in well-differentiated adipocytes.Molecules 2020, 25, x FOR PEER REVIEW 7 of 16 
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extract was not toxic at all concentrations and times considered (Figure 3A). Since baobab leaf extract 
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Figure 3. Cytotoxicity activity of extracts from baobab edible parts in SW-872 cells (MTS assay) (A,B).
Cells were differentiated with 100 µM oleic acid for 7 days and then were incubated for 24 (A) or 48 h
(B) with plant extracts. Data are derived from pooling of two separate experiments (total n = 4) and
are expressed as mean of percentage (%) inhibition (± SD). Effect of baobab extracts on adipocyte
differentiation of SW-872 cells with oleic acid (ORO staining) (C). SW-872 cells were incubated for 7 days
with 100 µM oleic acid, with or without 10 and 25 mg/mL baobab extracts. The red staining (ORO)
indicates relevant triglyceride accumulation (marker of adipocyte differentiation) (inverted phase
contrast microscopy; 20X magnification). The addition of 10 or 25 µg/mL baobab extracts to 100 µM
oleic acid did not affect triglyceride accumulation. Control: Untreated SW-872 cells (preadipocytes).
ABL: Baobab leaf extract; ABF: Baobab fruit pulp extract.
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2.3.2. Effect of Baobab Fruit Pulp and Leaf Extracts on SW-872 Cell Viability
The cytotoxicity of plant extracts was assayed by measuring cell viability with the MTS assay and
by morphological analysis. SW-872 cells were treated with increasing concentrations (0–100 µg/mL)
of baobab leaf and baobab fruit pulp extracts for 24 and 48 h. The viability threshold was set at 80%.
Toxicity was observed at 50 and 100 µg/mL for baobab leaf extract, both at 24 and 48 h (Figure 3A), while
at 10 µg/mL, baobab leaf extract only marginally affected cell viability. Baobab fruit pulp extract was not
toxic at all concentrations and times considered (Figure 3A). Since baobab leaf extract concentrations
below 50 µg/mL resulted as non-toxic, we used this or lower concentrations for further experiments.
An additional viability evaluation was conducted by examining cell morphology after treatment with
baobab extracts for 24 and 48 h. No morphological changes were observed for both extracts at 1 and
10 µg/mL at both times; whereas, at 100 µg/mL, baobab leaf extract, but not baobab fruit pulp extract,
resulted in toxic and severe morphological changes leading to cell death in SW-872 cells after 24- and
48-h treatments (Figure S1 in Supplementary Materials).
2.3.3. Effect of Baobab Fruit Pulp and Leaf Extracts on SW-872 Differentiation
The study of the effects of baobab extracts on the differentiation of SW-872 preadipocytes into
mature adipocytes was assessed evaluating TG accumulation by ORO staining and TG content
measurement. SW-872 cells were simultaneously treated with 100 µM oleic acid as a differentiating
agent, and baobab extracts at 10 and 25 µg/mL, for 7 days. We considered undifferentiated cells
as negative control and SW-872 cells treated only with oleic acid as a positive control (Figure 3B).
The addition of both baobab extracts at 10 and 25 µg/mL did not affect the extent of ORO staining
(Figure 3B). Moreover, the extent of TG accumulation by SW-872 cells in the presence of either baobab
extract was also quantified, using the same experimental paradigm reported above for ORO assessment.
As expected, TG content in SW-872 cells doubled after 7-day exposure to oleic acid. The simultaneous
addition of either baobab fruit extract or baobab leaf extract, however, did not significantly affect TG
accumulation (Table 1), indicating a neutral impact of these extracts on this parameter.
Table 1. Effect of baobab leaf extract and baobab fruit pulp extract on triglyceride accumulation in
SW-872 cells differentiated to adipocytes with 100 µM oleic acid (n = 3).
Cell Treatment mg/mL(Mean (SD)) %
Control 1.318 (0.131) 100
Oleic acid 2.821 (0.660) 214
Oleic acid + baobab leaf extract 3.158 (0.281) 240
Oleic acid + baobab fruit pulp extract 3.005 (0.213) 228
2.4. Molecular Docking
Recent evidence showed that flavonoids, especially flavonols, exert inhibitory activity against
the enzymes studied in this investigation [19–22]. In Table 2, the characterization of the polyphenol
binding sites is reported for alpha-glucosidase, alpha-amylase, 3-hydroxy-3-methylglutaryl-coenzyme
A reductase, pancreatic lipase, and angiotensin-converting enzyme.
Table 2. Polyphenol binding sites characterization.
Molecular
Target
Catalytic
Site
Allosteric
Site
Residues
Involved Ref.
Alpha-glucosidase
√
R407, R197, R407, F282 Jhong et al., 2015 [19]
Alpha-Amylase
√ K200, E233, D300, W151, A198,
L162 Jhong et al., 2015 [19]
3-Hydroxy-3-methylglutaryl-coenzyme
A reductase
(HMGCoAR)
√
(NADP binding site) K691, E559, D767 Islam et al., 2015 [20]
Pancreatic Lipase
√
F78, Y115, H152, F216 Martinez Gonzales et al., 2017 [21]
Angiotensin-converting enzyme (ACE)
√
S1′, S2′/S1′, S2′ regions Guerrero et al., 2012 [22]
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In light of this, and considering that quercetin, kaempferol, and their derivatives occur both in
baobab fruit pulp extract and in leaf extract, a pharmacophore model using flavonols available in the
baobab extracts was built to evaluate the pattern of common chemical features essential to biological
activity against potential targets. The pharmacophore generated by Ligand Scout was built by a training
set of four flavonols: quercetin, kaempferol, quercetrin, and rutin. It showed four main features:
(1) hydrogen bond acceptors (2) hydrogen bond donors, (3) aromatic rings, and (4) hydrophobic
regions. All the ligands highlighted consistency in these four features. In Figure 4, 3D, and 2D
views of the quercetin/kaempferol and quercitrin/rutin aligned pharmacophores were depicted.
The features identified in red and green colors are the H-bond donor and acceptor groups respectively;
the aromatic rings are shown in blue color and hydrophobic in yellow color in both views. Overall,
the pharmacophoric features for each are shown in Table S1 (Supplementary Material). Similar
features were identified after analyzing the pharmacophores of all compounds generated by Ligand
scout. The similar features of all compounds were then superimposed and merged into a single
pharmacophore as shown in Figure 5. Excluded volume spheres to reflect potential steric restrictions
were also added.
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3. Discussion
Since MS is a complex cluster of metabolic abnormalities, we decided to test extracts of baobab
edible parts to verify their ability to inhibit five enzyme activities involved in the development of MS
itself. Baobab extract inhibitory activities obtained by in vitro enzymatic assays were compared with
those of anti-hyperglycemic, antihypertensive, anti-hypercholesterolaemic, and anti-obesity drugs,
used as positive controls to check the validity of these enzymatic tests. According to the findings
obtained, the baobab fruit pulp and leaf extracts appeared to be the most interesting ones. On the
contrary, the seed extracts, both raw and toasted, did not show any relevant activity against these
enzymes, except for baobab raw seed extract, which showed good inhibitory activity against ACE.
This result suggests proceeding with further investigations, as plant extracts with antihypertensive
activity are limited in number and baobab seeds could be a source of extracts with such activity.
As far as baobab leaf extract is concerned, it was found to be the most active in all the enzymatic
assays. Our results are in agreement with literature data showing that baobab leaves possess potent
inhibitory activity against alpha-amylase and alpha-glucosidase enzymes and provide new knowledge
about the potential use of baobab leaf extract as an antihypertensive and antidyslipidemic agent [23].
Furthermore, these results provide an explanation of the mechanism of action underlying the evidence
obtained by in vivo studies on Adansonia digitata L. against MS, with baobab fruit pulp improving
glycemic response and satiety [24], reducing serum lipids [25], and maintaining glycemic control in
animals [11,26]; moreover, baobab leaf extract is able to reduce hyperglycemia and hyperlipidemia of
diabetic rats [14].
Baobab leaf and fruit pulp extracts, at non-toxic concentrations, did not affect TG accumulation
in SW-872 cells, taken here as an index of adipocyte differentiation, and thus, they did not reduce or
contrast adipogenic differentiation of SW-872 preadipocytes. It should be considered that in this study
adipogenesis was induced by oleic acid treatment, which is actually a potent adipogenic promoter that
acts via activation of nuclear PPARγ (peroxisome proliferator-activated receptor gamma), and thus,
these plant extracts may not be sufficiently effective in counteracting such molecular processes. In any
case, this observation also suggests that these extracts are not adipogenic in vitro. This requires further
studies in experimental animals and in humans, where they are not expected to promote obesity nor to
worsen pre-existing obesity.
In our previous investigation on baobab fruit pulp and baobab leaf extracts [18], we found many
flavonols (quercetin, kaempferol, and their derivatives) detected by targeted RP-HPLC-PDA-ESI-MS/MS
analysis. The results obtained from the enzyme inhibition assays can be explained considering the
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binding ability of the flavonols occurring in the baobab fruit pulp and leaf extracts towards the enzymes.
This hypothesis is supported by Literature data. Jhong et al. in a research communication using a
structure-based docking approach [19], screened 47 natural compounds against alpha-glucosidase
and alpha-amylase 3D crystal structures. The docking data showed that flavanols such as catechin,
quercetin, and rutin had binding ability towards alpha-amylase and alpha-glucosidase enzymes.
Analyzed alpha-glucosidase and alpha-amylase inhibitory activity revealed that the most interesting
inhibitors (below 0.5 mM) were flavonoids, and among these, quercetin and catechin were the most
potent, in comparison with the commercial drug acarbose. These compounds were found to favorably
bind the alpha-glucosidase active site, forming key interactions with R407, R197, R407, and F282
binding residues, similarly to the positive control acarbose. The top-ranked compounds scoring highly
on the alpha-amylase crystal structure, including catechin, quercetin, rutin, and other polyphenols,
were found to fit the alpha-amylase binding site by a network of H-bonds and electrostatic interactions
involving K200, E233, D300, W151, A198, and L162 binding site residues.
To explain polyphenol anticholesterol activities, flavonoids such as kaempferol, catechin,
and quercetin can bind to HMG-CoAR [20]. The X-ray crystal structure of human HMG-CoAR
reveals a HMG-CoA binding loop comprising of amino acid residues 682–694, the catalytic site of the
enzyme. Crucial interaction residues involved K691, E559, and D767. However, the NADP allosteric
cleft is also present in HMG-CoAR located near to the active site. Docking studies reported that the
rigid ring of phenols can fit the NADP binding site, competitively inhibiting NADPH and preventing
HMG-CoA access by steric effects. Recently, Martinez Gonzales et al. predicted the potential binding
sites of polyphenols in the pancreatic lipase binding cleft by conducting docking studies [21]. Moreover,
some studies have demonstrated that certain flavonoids can have inhibitory effects on different zinc
metalloproteinases such as ACE activity, which exhibited a key role in the regulation of arterial
blood pressure [27,28]. In 2012, Guerrero et al. [22] used SAR studies to describe the combinations of
substructures and functional groups on the flavonoid skeleton, which increase ACE activity. Moreover,
docking studies elucidate the molecular mechanism of these compounds on ACE activity. The results
highlighted how these flavonoids form intermolecular interactions with some of the ACE binding
site regions (i.e., S2′, S2′/S1′ and S1′), that are also involved in the binding of known ACE inhibitors.
Interestingly, flavonoids fit the S1 site of ACE, forming most of the intermolecular interactions as found
for synthetic ACE inhibitors (e.g., lisinopril, enalapril, captopril). The authors described for example
quercetin, rutin and kaempeferol contacted S2′ pocket T282, H353 binding residues, and S2′/S1′
region V379.
4. Materials and Methods
4.1. Materials and Reagents
Millipore-grade water was obtained from a LC-Pak™ Millex system (Millipore Corporation,
Billerica, MA, USA). Formic acid, methanol, alpha-amylase, sodium chloride, sodium phosphate
dibasic, sodium phosphate monobasic, starch, dinitrosalicylic acid, acarbose, alpha-glucosidase,
4-nitrophenyl-α-d-glucopyranoside, trichloroacetic acid, tris HCl, HMG-CoAR inhibition assay kit,
ACE,N-[3-(2-Furyl)acryloyl]-l-phenylalanyl-glycyl-glycine, captopril, porcine pancreatic lipase, p-NPB,
dimethylformamide, orlistat, and (3-(N-morpholino) propanesulfonic acid were purchased from
Sigma-Aldrich, St. Louis, MO, USA.
4.2. Preparation of Food Materials and Food Extracts
To perform a more representative sampling, five fresh baobab fruits (about 300 g), and 20 dried
leaves, raw and toasted (in an electric oven for 10 min at 240 ◦C) seeds (500 g) were collected during the
harvest season of January–February 2018, in a local market in Ngaoundéré, Cameroon. Baobab fruit
pulp samples were oven dried at 40 ◦C, milled, and mixed together. Baobab dried leaves were collected
and milled together. Baobab dried fruit pulp, dried leaves, and raw and toasted seeds were transported
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to Italy by airplane in plastic bags inside a box, where they were stored in vacuum plastic bags away
from sunlight in a cool room. Raw and toasted seeds were crushed in a mortar, ground, and mixed.
All the edible parts of baobab were submitted to extraction, which was carried out separately by
weighing 10 g of the food powder into a conical flask and then adding 100 mL of a mixture of acidified
Millipore grade water with formic acid (0.1%) to methanol (50:50 v/v). The conical flask, immersed in
an ice bath, was left stirring for 24 h under a nitrogen atmosphere. After 24 h, the mixture was filtered
under vacuum with paper filters (Whatman Grade 595 Qualitative Filter Papers), and the methanol
was evaporated under a stream of nitrogen. Finally, the obtained extract was frozen at −20 ◦C and then
freeze-dried to obtain a powder. The yields of extraction are reported above. The different extracts
were dissolved in the different buffers for the enzymatic assays. In our recent study of Tsetegho et al.
(2019), the baobab food extracts were characterized though RP-HPLC-PDA-ESI-MS/MS and NMR
spectroscopy to obtain a phytochemical profile [18].
4.3. In Vitro Enzymatic Assays
The enzyme inhibition assays were conducted according to the protocol described in the
Worthington enzyme manual, with some modifications [29]. For the alpha-amylase inhibition
assay, each food extract was diluted in a range of 0.01 to 40.00 mg/mL. For alpha-glucosidase inhibition
assay, each food extract was diluted in a range from 0.02 to 20.00 mg/mL. Acarbose was used as a
positive control in the concentration range of 0.20–0.01 mg/mL in both assays. For the HMG-CoAR
inhibition assay, the extracts were tested in a range from 0.50 to 40.00 mg/mL. Pravastatin was used as
a positive control. For the pancreatic lipase inhibition assay, each extract was diluted in a range from
1.00 to 40.00 mg/mL. Orlistat was used as a positive control. For ACE inhibition assay, each extract
was diluted in 50 mM Tris-HCl buffer (pH 7.5 with 0.3M NaCl) in a range from 0.07 to 20.00 mg/mL.
Captopril was used as a positive control. For all enzyme inhibition assays, the absorbance of sample
blanks (buffer in place of the enzyme solution) and a control (buffer in place of plant extract solution)
were recorded as well. The final sample absorbance was obtained by subtracting the corresponding
absorbance of the sample blank. The inhibition of enzyme activity was calculated according to the
equation below:
Inhibition (%) = ((Abs Control-Abs sample)/(Abs Control)) × 100 (1)
For all assays, experiments were performed three times (3 replicates).
The IC50 values were calculated using linear or polynomial regressions. Logarithmic transformations
were used to facilitate the calculations where necessary. Results are expressed as means ± SE,
and p < 0.05 was considered statistically significant. The statistical significance of the data was assessed
through a one-way variance analysis (ANOVA). When significant differences were found, Bonferroni
post hoc testing was used to determine the difference between the groups involved.
4.4. Evaluation of the Effects of Baobab Pulp and Leaf Plant Extracts on SW872 Human Liposarcoma Cells
Differentiated to Mature Adipocytes
4.4.1. SW-872 Cell Culture
The SW-872 human liposarcoma cell line (ATCC® HTB-92 ™) was obtained from the American
Type Culture Collection (ATCC®, Manassas, VA, USA) and grown as recommended by the latter. Cells
(undifferentiated preadipocytes and differentiated adipocytes) were cultured in DMEM/F-12 culture
medium (Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12), containing 15 mM of HEPES
buffer (N-[2-hydroxyethyl]piperazine-N′ [2-ethanolsulfonic acid] and sodium bicarbonate, to which
2 mM l-glutamine, 10% fetal bovine serum (FBS) and 1% penicillin (100 U/mL), and streptomycin
(100 µg/mL) were added. They were then kept in culture in 75 cm2 Petri dishes, at 37 ◦C at 95% air
and 5% CO2. The culture medium was renewed every 2 days. After 7 days of culture, 2 mL of a
trypsin-EDTA solution was added to the plate to detach the cells and then incubated at 37 ◦C for 5 min.
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Subsequently, the trypsin-EDTA-cell suspension was centrifuged at 1,200 rpm for 5 min to separate the
cells. The cell pellet was resuspended in 10 mL of medium containing 10% FBS.
4.4.2. Differentiation of SW-872 Preadipocytes to Mature Adipocytes
SW-872 preadipocyte cells were cultured as described above. After 24–48 h, oleic acid was added
directly to the plate to a final concentration of 100 µM. Medium change and addition of oleic acid were
repeated every 48 h. The differentiation treatment was prolonged for 7 days. After this treatment,
adipocytes maintained their differentiated state for at least 4 days without adding further oleic acid to
the medium.
4.4.3. Oil red O (ORO) Staining/Hematoxylin Counterstaining of Nuclei
After removing the medium, cells were washed with PBS and fixed with 4% formaldehyde
for 60 min and washed three times with water. Then, cells were incubated with the ORO working
solution (3 mg/mL) (Sigma-Aldrich, Milan, Italy) for 30 min. Cells were then washed 10 times
with water, nuclei were counterstained with hematoxylin, and the morphology was evaluated by
immunofluorescence microscopy.
4.4.4. Triglyceride Content Measurement
One of the main features determining the differentiation from preadipocytes to mature adipocytes
is the accumulation of triglycerides in the cell. To this aim, we used the Triglyceride Quantification
Kit (Sigma-Aldrich, Milan, Italy), which provides a sensitive assay to measure triglyceride (TG)
concentration, according to the protocol provided by the supplier. Briefly, in this assay, TGs are
converted to free fatty acids and glycerol. Glycerol was then oxidized to generate a colorimetric
(570 nm)/fluorometric (λex = 535 nm/λem = 587 nm) product. The kit is sensitive to detect 2
pmole–10 nmole (2–10,000 µM range) of TG. The protocol was adapted for use with SW-872 cell extracts
and all samples and standards were prepared in duplicate. Data were corrected for the background
and interpolated in an appropriate TG standard curve.
4.5. Ligand-Based Pharmacophore Modeling
The pharmacophore models were built using LigandScout 4.3 (InteLigand, Wien, Austria) from a
training set of four flavonol structures retrieved from the PubChem Repository [29]. For the training
set, 25 conformations were created with OMEGA-best settings implemented in LigandScout [30].
Successively, the conformations were clustered according to the similarity of the pharmacophore
radial distribution function (RDF). The program was set to create 10 shared feature pharmacophore
hypotheses ranked according to pharmacophore fit and atom overlap scoring function. In a shared
feature pharmacophore model generation, LigandScout generates pharmacophore models from the
chemical functionalities of the training compounds and aligns the molecules according to their
pharmacophores [31].
Only features present in all training molecules are considered for model building. For the best
alignment, common pharmacophore features are generated and assembled together, comprising the
final pharmacophore model. The shared feature pharmacophore models contain only chemical features
present in all the training molecules.
5. Conclusions
Currently, many drugs are used for their inhibitory activities against the enzymes involved in the
pathogenesis of MS. Most of these drugs present many side effects and are expensive. Thus, alternative
options are required to face these issues. Food extracts including plant extracts are very complex
and contain several active components, offering a higher probability of finding various components
that may target different metabolic pathways, thus suggesting the utility of food extracts in complex
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pathogenic processes, like MS, which involves many enzymes and metabolic pathways. The novel
data discussed in the present paper may thus help to support and explain the growing amount of
evidence on the nutritional and biological properties of baobab edible parts and provide suggestions
on their possible uses in food and nutraceutical fields, prompting European food companies to present
an application for authorization of a novel food in the context of Regulation (EU) 2015/2283, as already
done in the case of the baobab fruit (Regulation (EC) No. 258/97 (Commission Decision 2008/575/EC).
Supplementary Materials: The following are available online. Table S1: Pharmacophore features of the flavanols:
quercetin, kaempferol, quercitrin, rutin. Figure S1. Morphological study of SW-872 cells, differentiated with
100 µM oleic acid, after 48 h treatment with plant extracts.
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